Go Pro
→ Rickards Predicts: Trump to buy tiny $2 stock? (From Paradigm Press) (Ad)tc pixel Free OACC Stock Alerts

Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors

Oaktree Acquisition Corp. III Life Sciences logo
$10.70 +0.03 (+0.28%)
Closing price 06/29/2026 11:52 AM Eastern
Extended Trading
$10.70 0.00 (0.00%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

OACC vs. APPS, ABR, CSR, ESRT, and RPC

Should you buy Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? MarketBeat compares Oaktree Acquisition Corp. III Life Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oaktree Acquisition Corp. III Life Sciences include Digital Turbine (APPS), Arbor Realty Trust (ABR), Centerspace (CSR), Empire State Realty Trust (ESRT), and Ridgepost Capital (RPC). These companies are all part of the "trading" industry.

How does Oaktree Acquisition Corp. III Life Sciences compare to Digital Turbine?

Digital Turbine (NASDAQ:APPS) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

Digital Turbine presently has a consensus target price of $8.75, suggesting a potential downside of 32.22%. Given Digital Turbine's stronger consensus rating and higher possible upside, equities analysts clearly believe Digital Turbine is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digital Turbine
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.75
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Digital Turbine has a beta of 2.84, meaning that its stock price is 184% more volatile than the broader market. Comparatively, Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

In the previous week, Digital Turbine had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 3 mentions for Digital Turbine and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Digital Turbine's score of 0.63 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Digital Turbine Positive
Oaktree Acquisition Corp. III Life Sciences Very Positive

Oaktree Acquisition Corp. III Life Sciences has lower revenue, but higher earnings than Digital Turbine.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Turbine$565.25M2.76-$37.73M-$0.36N/A
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A

63.7% of Digital Turbine shares are held by institutional investors. 6.1% of Digital Turbine shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Oaktree Acquisition Corp. III Life Sciences has a net margin of 0.00% compared to Digital Turbine's net margin of -6.68%. Digital Turbine's return on equity of 27.60% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Digital Turbine-6.68% 27.60% 5.68%
Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A

Summary

Digital Turbine beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 13 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Arbor Realty Trust?

Arbor Realty Trust (NYSE:ABR) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap trading companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

Arbor Realty Trust has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, suggesting that its stock price is 101% less volatile than the broader market.

Arbor Realty Trust has a net margin of 12.73% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Arbor Realty Trust's return on equity of 8.49% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Arbor Realty Trust12.73% 8.49% 1.46%
Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A

Arbor Realty Trust presently has a consensus target price of $8.00, suggesting a potential upside of 49.34%. Given Arbor Realty Trust's stronger consensus rating and higher possible upside, equities analysts plainly believe Arbor Realty Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arbor Realty Trust
4 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.50
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Arbor Realty Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arbor Realty Trust$940.01M1.10$148.80M$0.3913.74
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A

57.3% of Arbor Realty Trust shares are held by institutional investors. 4.2% of Arbor Realty Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Arbor Realty Trust had 4 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 5 mentions for Arbor Realty Trust and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Arbor Realty Trust's score of 0.85 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Arbor Realty Trust Positive
Oaktree Acquisition Corp. III Life Sciences Very Positive

Summary

Arbor Realty Trust beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Centerspace?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Centerspace (NYSE:CSR) are both small-cap trading companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

Centerspace has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Centerspace$273.66M3.49$17.59M$0.45126.22

In the previous week, Centerspace had 5 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 6 mentions for Centerspace and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Centerspace's score of 1.60 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
Centerspace Very Positive

79.0% of Centerspace shares are held by institutional investors. 0.5% of Centerspace shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Centerspace has a consensus target price of $68.80, suggesting a potential upside of 21.13%. Given Centerspace's stronger consensus rating and higher probable upside, analysts plainly believe Centerspace is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Centerspace
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Centerspace has a net margin of 2.93% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Centerspace's return on equity of 0.94% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Centerspace 2.93%0.94%0.40%

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, meaning that its share price is 101% less volatile than the broader market. Comparatively, Centerspace has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

Centerspace beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Empire State Realty Trust?

Empire State Realty Trust (NYSE:ESRT) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap trading companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

Empire State Realty Trust has a net margin of 5.09% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Empire State Realty Trust's return on equity of 2.19% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Empire State Realty Trust5.09% 2.19% 0.93%
Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A

Empire State Realty Trust has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market. Comparatively, Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

Empire State Realty Trust presently has a consensus target price of $5.92, indicating a potential upside of 11.11%. Given Empire State Realty Trust's stronger consensus rating and higher possible upside, analysts clearly believe Empire State Realty Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Empire State Realty Trust
2 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.33
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Empire State Realty Trust had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 3 mentions for Empire State Realty Trust and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Empire State Realty Trust's score of 0.46 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Empire State Realty Trust Neutral
Oaktree Acquisition Corp. III Life Sciences Very Positive

67.1% of Empire State Realty Trust shares are owned by institutional investors. 15.2% of Empire State Realty Trust shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Empire State Realty Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empire State Realty Trust$768.27M1.20$47.60M$0.2620.48
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A

Summary

Empire State Realty Trust beats Oaktree Acquisition Corp. III Life Sciences on 10 of the 11 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Ridgepost Capital?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Ridgepost Capital (NYSE:RPC) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

Ridgepost Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Ridgepost Capital$304.70M2.73$19.50M$0.2234.60

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, indicating that its share price is 101% less volatile than the broader market. Comparatively, Ridgepost Capital has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market.

Ridgepost Capital has a consensus target price of $12.00, indicating a potential upside of 57.65%. Given Ridgepost Capital's stronger consensus rating and higher possible upside, analysts plainly believe Ridgepost Capital is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Ridgepost Capital
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

Ridgepost Capital has a net margin of 7.99% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Ridgepost Capital's return on equity of 24.58% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Ridgepost Capital 7.99%24.58%10.56%

48.0% of Ridgepost Capital shares are owned by institutional investors. 11.8% of Ridgepost Capital shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Ridgepost Capital had 1 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 2 mentions for Ridgepost Capital and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Ridgepost Capital's score of 0.54 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
Ridgepost Capital Positive

Summary

Ridgepost Capital beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks.

Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OACC vs. The Competition

Export
MetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinancial SectorNASDAQ Exchange
Market Cap$262.30M$311.26M$6.09B$12.20B
Dividend YieldN/AN/A5.24%6.22%
P/E RatioN/A2.3229.3324.54
Price / SalesN/A172.551,463.99100.81
Price / CashN/A140.1148.6036.93
Price / BookN/A348.876.546.49
Net IncomeN/A-$66.54M$1.13B$336.61M
7 Day Performance0.28%0.00%0.21%1.20%
1 Month Performance0.19%-0.82%0.11%0.20%
1 Year Performance2.39%1.69%17.78%30.15%

Oaktree Acquisition Corp. III Life Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OACC
Oaktree Acquisition Corp. III Life Sciences
N/A$10.70
+0.3%		N/A+2.0%$262.30MN/AN/AN/A
APPS
Digital Turbine
2.7022 of 5 stars		$8.61
flat		$8.75
+1.6%		+125.3%$1.04B$565.25MN/A840
ABR
Arbor Realty Trust
4.6921 of 5 stars		$5.19
-0.3%		$8.00
+54.3%		-49.3%$997.39M$940.01M13.29630
CSR
Centerspace
4.8563 of 5 stars		$55.46
-0.3%		$68.80
+24.1%		-5.5%$931.71M$273.66M123.24470
ESRT
Empire State Realty Trust
2.2938 of 5 stars		$5.23
-0.3%		$5.92
+13.2%		-34.3%$901.12M$768.27M20.10670

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OACC) was last updated on 6/30/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
The startup growing 23 times faster than Nvidia
An official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes ...
Brownstone Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Gold Is About to Do Something It Hasn’t in 90 Years
The U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...
US Gold Bureau | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel